Also, the transcriptional analyses in the study by Noorbakhsh et al. showed significantly lower SRD5A1 transcripts in the white matter of MS patients postmortem compared to corresponding control samples [18]. The gene discussed is SRD5A1; the disease is myeloid sarcoma.